No Difference in Brain Activation During Cognitive Performance Between Ecstasy (3,4-Methylenedioxymethamphetamine) Users and Control Subjects: A [H215O]-Positron Emission Tomography Study Read More > February 1, 2001
Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action Read More > December 1, 1998
Serotonergic Agents That Activate 5HT2A Receptors Prevent NMDA Antagonist Neurotoxicity Read More > July 2, 1997
Ketamine psychedelic therapy (KPT): a review of the results of ten years of research Read More > January 1, 1997
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis Read More > October 14, 1996
Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity Read More > April 2, 1995
